Cell And Gene Therapy Third-Party Logistics Market Size, Share & Trends Analysis Report By Type, By Product, By Temperature Range, By Therapeutic Area, By End-use, By Region, And Segment Forecasts, 2025

The global cell and gene therapy third-party logistics market is expected to reach USD 20.04 billion by 2030, expanding at a CAGR of 11.05% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is mainly due to rising demand for cell and gene therapies, which require precise handling, strict temperature controls, and seamless coordination between manufacturers, hospitals, and treatment centers. CGTs are patient-specific, which signifies that a single patient's cells must be collected, transported, modified, and reinfused within tight timelines. Any failure in logistics can result in the loss of an expensive, potentially life-saving therapy. The personalized nature of CGTs has increased the need for advanced cold chain logistics, with cryogenic storage and ultra-low temperature transportation becoming standard requirements.

In addition, the growing pipeline of CGT clinical trials and commercial approvals encourages logistics providers to scale their capabilities, ensuring that the increasing volume of therapies reaches patients without compromising quality. This shift is compelling biopharmaceutical companies to seek specialized 3PL partners that can handle the complexities of CGT supply chains, ensuring compliance with strict regulatory requirements while optimizing distribution efficiency. Moreover, the growing regulatory support is also one of the factors contributing to market growth. The U.S. FDA, EMA, and other global regulatory bodies impose stringent guidelines on the transportation and storage of CGTs to maintain their potency and safety. Regulatory compliance requires logistics providers to implement Good Distribution Practices (GDP) and Good Manufacturing Practices (GMP) standards, which govern every aspect of supply chain management, from packaging to real-time tracking. Failure to comply can result in rejected shipments, financial losses, and treatment delays for patients.

Furthermore, growing initiatives by the market players, such as partnerships and collaborations, service expansion, product launches, and increasing pipeline products, contribute to market growth. For instance, in March 2025, DHL acquired CryoPDP, a specialist in temperature-controlled logistics for life sciences. The acquisition aims to strengthen the infrastructure for handling advanced therapies. CryoPDP's expertise in ultra-cold storage and real-time monitoring solutions aligns with DHL's strategy, providing end-to-end solutions for biopharma companies.

Cell And Gene Therapy Third-Party Logistics Market Report Highlights:

Based on type, the clinical segment dominated the market due to the increasing number of research and development activities by the market players coupled with the growing number of cell and gene therapies product pipelines.
Based on the product, cell therapies dominated the market in 2024 due to increasing regulatory approvals and expanding commercialization efforts. The success of CAR-T cell therapies for cancer treatment played a crucial role in this growth, with companies like Novartis, Gilead Sciences, and Bristol Myers Squibb driving widespread adoption.
Based on temperature range, ambient storage held the largest market share in 2024due to the increasing demand for gene therapies, biologics, and regenerative medicine products that do not require ultra-low or cryogenic temperatures.
Based on the therapeutic area, the oncology segment dominated the market in 2024due to the rapid adoption of advanced therapies for treating various cancers, particularly hematologic and solid tumors.
Based on end use, biopharmaceutical companies held the largest market share in 2024due to their high reliance on temperature-controlled storage and transportation for biologics and specialty drugs.

Product Code: GVR-4-68040-550-5

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
- 1.1.1. Regional Scope
- 1.1.2. Estimates and Forecast Timeline
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Purchased Database
- 1.3.3. GVR's Internal Database
- 1.3.4. Secondary Sources
- 1.3.5. Primary Research
1.4. Information or Data Analysis
- 1.4.1. Information Analysis
- 1.4.2. Market Formulation & Data Visualization
- 1.4.3. Data Validation & Publishing
1.5. Model Details
- 1.5.1. Commodity Flow Analysis (Model 1)
- 1.5.2. Top Down Market Estimation (Model 2)
- 1.5.3. Value-Chain-Based Sizing & Forecasting (Model 3)
- 1.5.4. Multivariate Analysis (Model 4)
1.6. List of Secondary Sources
1.7. List of Abbreviations
1.8. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
- 3.3.1. Market Driver Analysis
- 3.3.2. Market Restraint Analysis
3.4. Technology Landscape
3.5. Pricing Model Analysis
3.6. Industry Analysis Tools
- 3.6.1. Porter's Five Forces Analysis
- 3.6.2. PESTEL Analysis
- 3.6.3. COVID-19 Impact Analysis

Chapter 4. Cell & Gene Therapy Third-Party Logistics Market: Type Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Cell & Gene Therapy Third-Party Logistics Market; Type Movement Analysis
4.3. Cell & Gene Therapy Third-Party Logistics Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Clinical
- 4.4.1. Clinical market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Commercial
- 4.5.1. Commercial market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Cell & Gene Therapy Third-Party Logistics Market: Product Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Cell & Gene Therapy Third-Party Logistics Market; Product Movement Analysis
5.3. Cell & Gene Therapy Third-Party Logistics Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
5.4. Cell Therapies
- 5.4.1. Cell therapies market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Gene Therapies
- 5.5.1. Gene therapies market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Cell & Gene Therapy Third-Party Logistics Market: Temperature Range Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Cell & Gene Therapy Third-Party Logistics Market; Temperature Range Movement Analysis
6.3. Cell & Gene Therapy Third-Party Logistics Size & Trend Analysis, by Temperature Range, 2018 to 2030 (USD Million)
6.4. Ambient Storage
- 6.4.1. Ambient storage market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Refrigerated Storage
- 6.5.1. Refrigerated storage market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Ultra-Low Temperature Storage
- 6.6.1. Ultra-Low temperature storage market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. Cryogenic Storage
- 6.7.1. Cryogenic storage market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Cell & Gene Therapy Third-Party Logistics Market: Therapeutic Area Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. Cell & Gene Therapy Third-Party Logistics Market; Therapeutic Area Movement Analysis
7.3. Cell & Gene Therapy Third-Party Logistics Size & Trend Analysis, by Therapeutic Area, 2018 to 2030 (USD Million)
7.4. Oncology
- 7.4.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Neurology
- 7.5.1. Neurology market estimates and forecasts, 2018 to 2030 (USD Million)
7.6. Cardiovascular Diseases
- 7.6.1. Cardiovascular diseases market estimates and forecasts, 2018 to 2030 (USD Million)
7.7. Ophthalmology
- 7.7.1. Ophthalmology market estimates and forecasts, 2018 to 2030 (USD Million)
7.8. Infectious Diseases
- 7.8.1. Infectious diseases market estimates and forecasts, 2018 to 2030 (USD Million)
7.9. Others
- 7.9.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Cell & Gene Therapy Third-Party Logistics Market: End Use Estimates & Trend Analysis

8.1. Segment Dashboard
8.2. Cell & Gene Therapy Third-Party Logistics Market; End Use Movement Analysis
8.3. Cell & Gene Therapy Third-Party Logistics Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
8.4. Biopharmaceutical Companies
- 8.4.1. Biopharmaceutical Companies market estimates and forecasts, 2018 to 2030 (USD Million)
8.5. CDMOs/CMOs
- 8.5.1. CDMOs/CMOs market estimates and forecasts, 2018 to 2030 (USD Million)
8.6. Others
- 8.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 9. Regional Business Analysis

9.1. Regional Dashboard
9.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
9.3. North America
- 9.3.1. North America cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
- 9.3.2. U.S.
  - 9.3.2.1. Key country dynamics
  - 9.3.2.2. Competitive scenario
  - 9.3.2.3. Regulatory framework
  - 9.3.2.4. U.S. cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
- 9.3.3. Canada
  - 9.3.3.1. Key country dynamics
  - 9.3.3.2. Competitive scenario
  - 9.3.3.3. Regulatory framework
  - 9.3.3.4. Canada cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
- 9.3.4. Mexico
  - 9.3.4.1. Key country dynamics
  - 9.3.4.2. Competitive scenario
  - 9.3.4.3. Regulatory framework
  - 9.3.4.4. Mexico cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
9.4. Europe
- 9.4.1. Europe cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
- 9.4.2. Germany
  - 9.4.2.1. Key country dynamics
  - 9.4.2.2. Competitive scenario
  - 9.4.2.3. Regulatory framework
  - 9.4.2.4. Germany cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
- 9.4.3. UK
  - 9.4.3.1. Key country dynamics
  - 9.4.3.2. Competitive scenario
  - 9.4.3.3. Regulatory framework
  - 9.4.3.4. UK cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
- 9.4.4. France
  - 9.4.4.1. Key country dynamics
  - 9.4.4.2. Competitive scenario
  - 9.4.4.3. Regulatory framework
  - 9.4.4.4. France cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
- 9.4.5. Italy
  - 9.4.5.1. Key country dynamics
  - 9.4.5.2. Competitive scenario
  - 9.4.5.3. Regulatory framework
  - 9.4.5.4. Italy cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
- 9.4.6. Spain
  - 9.4.6.1. Key country dynamics
  - 9.4.6.2. Competitive scenario
  - 9.4.6.3. Regulatory framework
  - 9.4.6.4. Spain cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
- 9.4.7. Denmark
  - 9.4.7.1. Key country dynamics
  - 9.4.7.2. Competitive scenario
  - 9.4.7.3. Regulatory framework
  - 9.4.7.4. Denmark cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
- 9.4.8. Sweden
  - 9.4.8.1. Key country dynamics
  - 9.4.8.2. Competitive scenario
  - 9.4.8.3. Regulatory framework
  - 9.4.8.4. Sweden cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
- 9.4.9. Norway
  - 9.4.9.1. Key country dynamics
  - 9.4.9.2. Competitive scenario
  - 9.4.9.3. Regulatory framework
  - 9.4.9.4. Norway cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
9.5. Asia Pacific
- 9.5.1. Asia Pacific cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
- 9.5.2. Japan
  - 9.5.2.1. Key country dynamics
  - 9.5.2.2. Competitive scenario
  - 9.5.2.3. Regulatory framework
  - 9.5.2.4. Japan cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
- 9.5.3. China
  - 9.5.3.1. Key country dynamics
  - 9.5.3.2. Competitive scenario
  - 9.5.3.3. Regulatory framework
  - 9.5.3.4. China cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
- 9.5.4. India
  - 9.5.4.1. Key country dynamics
  - 9.5.4.2. Competitive scenario
  - 9.5.4.3. Regulatory framework
  - 9.5.4.4. India cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
- 9.5.5. South Korea
  - 9.5.5.1. Key country dynamics
  - 9.5.5.2. Competitive scenario
  - 9.5.5.3. Regulatory framework
  - 9.5.5.4. South Korea cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
- 9.5.6. Australia
  - 9.5.6.1. Key country dynamics
  - 9.5.6.2. Competitive scenario
  - 9.5.6.3. Regulatory framework
  - 9.5.6.4. Australia cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
- 9.5.7. Thailand
  - 9.5.7.1. Key country dynamics
  - 9.5.7.2. Competitive scenario
  - 9.5.7.3. Regulatory framework
  - 9.5.7.4. Thailand cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
9.6. Latin America
- 9.6.1. Latin America cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
- 9.6.2. Brazil
  - 9.6.2.1. Key country dynamics
  - 9.6.2.2. Competitive scenario
  - 9.6.2.3. Regulatory framework
  - 9.6.2.4. Brazil cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
- 9.6.3. Argentina
  - 9.6.3.1. Key country dynamics
  - 9.6.3.2. Competitive scenario
  - 9.6.3.3. Regulatory framework
  - 9.6.3.4. Argentina cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
9.7. MEA
- 9.7.1. MEA cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
- 9.7.2. South Africa
  - 9.7.2.1. Key country dynamics
  - 9.7.2.2. Competitive scenario
  - 9.7.2.3. Regulatory framework
  - 9.7.2.4. South Africa cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
- 9.7.3. Saudi Arabia
  - 9.7.3.1. Key country dynamics
  - 9.7.3.2. Competitive scenario
  - 9.7.3.3. Regulatory framework
  - 9.7.3.4. Saudi Arabia cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
- 9.7.4. UAE
  - 9.7.4.1. Key country dynamics
  - 9.7.4.2. Competitive scenario
  - 9.7.4.3. Regulatory framework
  - 9.7.4.4. UAE cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
- 9.7.5. Kuwait
  - 9.7.5.1. Key country dynamics
  - 9.7.5.2. Competitive scenario
  - 9.7.5.3. Regulatory framework
  - 9.7.5.4. Kuwait cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

10.1. Company Categorization
10.2. Company Market Share/Assessment Analysis, 2024
10.3. Company Profiles
- 10.3.1. Cencora Corporation
  - 10.3.1.1. Company overview
  - 10.3.1.2. Financial performance
  - 10.3.1.3. Service benchmarking
  - 10.3.1.4. Strategic initiatives
- 10.3.2. Cardinal Health
  - 10.3.2.1. Company overview
  - 10.3.2.2. Financial performance
  - 10.3.2.3. Service benchmarking
  - 10.3.2.4. Strategic initiatives
- 10.3.3. McKesson Corporation
  - 10.3.3.1. Company overview
  - 10.3.3.2. Financial performance
  - 10.3.3.3. Service benchmarking
  - 10.3.3.4. Strategic initiatives
- 10.3.4. EVERSANA
  - 10.3.4.1. Company overview
  - 10.3.4.2. Financial performance
  - 10.3.4.3. Service benchmarking
  - 10.3.4.4. Strategic initiatives
- 10.3.5. Knipper Health
  - 10.3.5.1. Company overview
  - 10.3.5.2. Financial performance
  - 10.3.5.3. Service benchmarking
  - 10.3.5.4. Strategic initiatives
- 10.3.6. Arvato SE
  - 10.3.6.1. Company overview
  - 10.3.6.2. Financial performance
  - 10.3.6.3. Service benchmarking
  - 10.3.6.4. Strategic initiatives
- 10.3.7. DHL
  - 10.3.7.1. Company overview
  - 10.3.7.2. Financial performance
  - 10.3.7.3. Service benchmarking
  - 10.3.7.4. Strategic initiatives
- 10.3.8. FedEx
  - 10.3.8.1. Company overview
  - 10.3.8.2. Financial performance
  - 10.3.8.3. Service benchmarking
  - 10.3.8.4. Strategic initiatives
- 10.3.9. Kuehne+Nagel
  - 10.3.9.1. Company overview
  - 10.3.9.2. Financial performance
  - 10.3.9.3. Service benchmarking
  - 10.3.9.4. Strategic initiatives
- 10.3.10. United Parcel Service of America, Inc.
  - 10.3.10.1. Company overview
  - 10.3.10.2. Financial performance
  - 10.3.10.3. Service benchmarking
  - 10.3.10.4. Strategic initiatives

Product Code: GVR-4-68040-550-5

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
Table 4 Global Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
Table 5 Global Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
Table 6 Global Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 7 Global Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
Table 8 Global Cell & Gene Therapy Third-Party Logistics Market, by Region, 2018 - 2030 (USD Million)
Table 9 North America Cell & Gene Therapy Third-Party Logistics Market, by Country, 2018 - 2030 (USD Million)
Table 10 North America Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
Table 11 North America Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
Table 12 North America Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
Table 13 North America Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 14 North America Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
Table 15 U.S. Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
Table 16 U.S. Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
Table 17 U.S. Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
Table 18 U.S. Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 19 U.S. Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
Table 20 Canada Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
Table 21 Canada Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
Table 22 Canada Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
Table 23 Canada Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 24 Canada Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
Table 25 Mexico Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
Table 26 Mexico Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
Table 27 Mexico Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
Table 28 Mexico Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 29 Mexico Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
Table 30 Europe Cell & Gene Therapy Third-Party Logistics Market, by Country, 2018 - 2030 (USD Million)
Table 31 Europe Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
Table 32 Europe Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
Table 33 Europe Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
Table 34 Europe Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 35 Europe Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
Table 36 UK Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
Table 37 UK Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
Table 38 UK Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
Table 39 UK Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 40 UK Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
Table 41 Germany Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
Table 42 Germany Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
Table 43 Germany Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
Table 44 Germany Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 45 Germany Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
Table 46 France Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
Table 47 France Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
Table 48 France Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
Table 49 France Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 50 France Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
Table 51 Italy Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
Table 52 Italy Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
Table 53 Italy Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
Table 54 Italy Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 55 Italy Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
Table 56 Spain Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
Table 57 Spain Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
Table 58 Spain Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
Table 59 Spain Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 60 Spain Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
Table 61 Denmark Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
Table 62 Denmark Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
Table 63 Denmark Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
Table 64 Denmark Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 65 Denmark Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
Table 66 Sweden Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
Table 67 Sweden Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
Table 68 Sweden Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
Table 69 Sweden Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 70 Sweden Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
Table 71 Norway Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
Table 72 Norway Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
Table 73 Norway Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
Table 74 Norway Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 75 Norway Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
Table 76 Asia Pacific Cell & Gene Therapy Third-Party Logistics Market, by Country, 2018 - 2030 (USD Million)
Table 77 Asia Pacific Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
Table 78 Asia Pacific Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
Table 79 Asia Pacific Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
Table 80 Asia Pacific Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 81 Asia Pacific Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
Table 82 Japan Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
Table 83 Japan Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
Table 84 Japan Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
Table 85 Japan Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 86 Japan Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
Table 87 China Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
Table 88 China Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
Table 89 China Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
Table 90 China Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 91 China Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
Table 92 India Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
Table 93 India Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
Table 94 India Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
Table 95 India Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 96 India Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
Table 97 Australia Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
Table 98 Australia Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
Table 99 Australia Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
Table 100 Australia Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 101 Australia Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
Table 102 South Korea Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
Table 103 South Korea Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
Table 104 South Korea Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
Table 105 South Korea Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 106 South Korea Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
Table 107 Thailand Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
Table 108 Thailand Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
Table 109 Thailand Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
Table 110 Thailand Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 111 Thailand Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
Table 112 Latin America Cell & Gene Therapy Third-Party Logistics Market, by Country, 2018 - 2030 (USD Million)
Table 113 Latin America Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
Table 114 Latin America Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
Table 115 Latin America Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
Table 116 Latin America Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 117 Latin America Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
Table 118 Brazil Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
Table 119 Brazil Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
Table 120 Brazil Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
Table 121 Brazil Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 122 Brazil Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
Table 123 Argentina Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
Table 124 Argentina Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
Table 125 Argentina Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
Table 126 Argentina Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 127 Argentina Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
Table 128 MEA Cell & Gene Therapy Third-Party Logistics Market, by Country, 2018 - 2030 (USD Million)
Table 129 MEA Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
Table 130 MEA Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
Table 131 MEA Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
Table 132 MEA Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 133 MEA Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
Table 134 South Africa Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
Table 135 South Africa Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
Table 136 South Africa Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
Table 137 South Africa Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 138 South Africa Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
Table 139 Saudi Arabia Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
Table 140 Saudi Arabia Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
Table 141 Saudi Arabia Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
Table 142 Saudi Arabia Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 143 Saudi Arabia Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
Table 144 UAE Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
Table 145 UAE Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
Table 146 UAE Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
Table 147 UAE Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 148 UAE Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
Table 149 Kuwait Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
Table 150 Kuwait Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
Table 151 Kuwait Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
Table 152 Kuwait Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 153 Kuwait Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 Cell & Gene Therapy Third-Party Logistics Market Segmentation
Fig. 7 Market Snapshot, 2024
Fig. 8 Market Trends & Outlook
Fig. 9 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 10 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 12 Porter's Five Forces Analysis
Fig. 13 Global Cell & Gene Therapy Third-Party Logistics Market: Type Key Takeaways
Fig. 14 Global Cell & Gene Therapy Third-Party Logistics Market: Type Movement Analysis
Fig. 15 Global Cell & Gene Therapy Third-Party Logistics Market, for Clinical, 2018 - 2030 (USD Million)
Fig. 16 Global Cell & Gene Therapy Third-Party Logistics Market, for Commercial, 2018 - 2030 (USD Million)
Fig. 17 Global Cell & Gene Therapy Third-Party Logistics Market: Product Key Takeaways
Fig. 18 Global Cell & Gene Therapy Third-Party Logistics Market: Product Movement Analysis
Fig. 19 Global Cell & Gene Therapy Third-Party Logistics Market, for Cell Therapies, 2018 - 2030 (USD Million)
Fig. 20 Global Cell & Gene Therapy Third-Party Logistics Market, for Gene Therapies, 2018 - 2030 (USD Million)
Fig. 21 Global Cell & Gene Therapy Third-Party Logistics Market: Temperature Range Key Takeaways
Fig. 22 Global Cell & Gene Therapy Third-Party Logistics Market, Temperature Range Movement Analysis
Fig. 23 Global Cell & Gene Therapy Third-Party Logistics Market, for Ambient Storage, 2018 - 2030 (USD Million)
Fig. 24 Global Cell & Gene Therapy Third-Party Logistics Market, for Refrigerated Storage, 2018 - 2030 (USD Million)
Fig. 25 Global Cell & Gene Therapy Third-Party Logistics Market, for Ultra-Low Temperature Storage, 2018 - 2030 (USD Million)
Fig. 26 Global Cell & Gene Therapy Third-Party Logistics Market, for Cryogenic Storage, 2018 - 2030 (USD Million)
Fig. 27 Global Cell & Gene Therapy Third-Party Logistics Market: Therapeutic Area Key Takeaways
Fig. 28 Global Cell & Gene Therapy Third-Party Logistics Market, Therapeutic Area Movement Analysis
Fig. 29 Global Cell & Gene Therapy Third-Party Logistics Market, Oncology, 2018 - 2030 (USD Million)
Fig. 30 Global Cell & Gene Therapy Third-Party Logistics Market, for Neurology, 2018 - 2030 (USD Million)
Fig. 31 Global Cell & Gene Therapy Third-Party Logistics Market, for cardiovascular diseases, 2018 - 2030 (USD Million)
Fig. 32 Global Cell & Gene Therapy Third-Party Logistics Market, for Ophthalmology, 2018 - 2030 (USD Million)
Fig. 33 Global Cell & Gene Therapy Third-Party Logistics Market, for Infectious Diseases, 2018 - 2030 (USD Million)
Fig. 34 Global Cell & Gene Therapy Third-Party Logistics Market, for Others, 2018 - 2030 (USD Million)
Fig. 35 Global Cell & Gene Therapy Third-Party Logistics Market: End Use Key Takeaways
Fig. 36 Global Cell & Gene Therapy Third-Party Logistics Market, End Use Movement Analysis
Fig. 37 Global Cell & Gene Therapy Third-Party Logistics Market, for Biopharmaceutical Companies, 2018 - 2030 (USD Million)
Fig. 38 Global Cell & Gene Therapy Third-Party Logistics Market, for CDMOs/CMOs, 2018 - 2030 (USD Million)
Fig. 39 Global Cell & Gene Therapy Third-Party Logistics Market, for Others, 2018 - 2030 (USD Million)
Fig. 40 Regional Marketplace: Key Takeaways
Fig. 41 Regional Outlook, 2024 & 2030
Fig. 42 North America Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
Fig. 43 U.S. Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
Fig. 44 Canada Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
Fig. 45 Mexico Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
Fig. 46 Europe Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
Fig. 47 Germany Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
Fig. 48 UK Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
Fig. 49 France Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
Fig. 50 Italy Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
Fig. 51 Spain Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
Fig. 52 Denmark Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
Fig. 53 Sweden Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
Fig. 54 Norway Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
Fig. 55 Asia Pacific Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
Fig. 56 Japan Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
Fig. 57 China Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
Fig. 58 India Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
Fig. 59 Australia Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
Fig. 60 South Korea Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
Fig. 61 Thailand Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
Fig. 62 Latin America Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
Fig. 63 Brazil Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
Fig. 64 Argentina Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
Fig. 65 Middle East and Africa Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
Fig. 66 South Africa Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
Fig. 67 Saudi Arabia Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
Fig. 68 UAE Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
Fig. 69 Kuwait Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)

Cell And Gene Therapy Third-Party Logistics Market Size, Share & Trends Analysis Report By Type, By Product, By Temperature Range, By Therapeutic Area, By End-use, By Region, And Segment Forecasts, 2025 - 2030

Description

Table of Contents

List of Tables

Cell & Gene Therapy Third-Party Logistics Market Growth & Trends:

Cell And Gene Therapy Third-Party Logistics Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Market Variables, Trends, & Scope

Chapter 4. Cell & Gene Therapy Third-Party Logistics Market: Type Estimates & Trend Analysis

Chapter 5. Cell & Gene Therapy Third-Party Logistics Market: Product Estimates & Trend Analysis

Chapter 6. Cell & Gene Therapy Third-Party Logistics Market: Temperature Range Estimates & Trend Analysis

Chapter 7. Cell & Gene Therapy Third-Party Logistics Market: Therapeutic Area Estimates & Trend Analysis

Chapter 8. Cell & Gene Therapy Third-Party Logistics Market: End Use Estimates & Trend Analysis

Chapter 9. Regional Business Analysis

Chapter 10. Competitive Landscape

List of Tables

List of Figures